|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Fibronectin-Binding Protein Peptide D3>> Market Analysis Reports |
Market Analysis Reports of Fibronectin-Binding Protein Peptide D3 |
|
Global Market Report of FIBRONECTIN-BINDING PROTEIN PEPTIDE D3 (CAS 119977-20-7) December 2024 Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2018 Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2018 SUMMARY Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1 ... Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2018 Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2018 SUMMARY Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1 ... Integrin Beta 1 - Pipeline Review, H2 2019 Integrin Beta 1 - Pipeline Review, H2 2019 SUMMARY Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Integrin beta-1 also known as CD29 is a protein encoded by the ITGB1 gene. It is involved ... Soft Tissue Sarcoma - Pipeline Insight, 2021 ... specific to the extra-domain B of fibronectin (L19) in the single-chain ... and PD-L2 ligands on their surface. Nivolumab binds to PD-1, preventing PD-L1 and PD-L2 from ... therapy Immunotherapy Nanoparticle Peptide Recombinant fusion protein Small molecule Product ... 2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the ... Innovative Cancer Diagnostic Technologies and Emerging Markets This unique 1,200-page report contains 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section. This comprehensive seven- ... Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years - Examines trends in the U. S., ... 2012 World Cancer Diagnostics Market Strategic Analysis: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country The report contains 1,200 pages, 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section. This comprehensive seven-country ... World Cancer Diagnostic Testing Market 2014: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. This new report from Venture Planning Group contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as ... Future Horizons in the European Cancer Diagnostics Market--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in ... European Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities This unique report contains 820 pages, 320 tables and provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major ... European Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities This unique report contains 820 pages, 320 tables and provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major ... 2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in ... 2013 Analysis of the European Tumor Marker Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in ... Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in ... Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market ... 2014 Analysis of the Tumor Marker Testing Market in Europe: Market Segment Forecasts and Supplier Shares This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in ... Tumor Marker Testing Market in Europe 2014: Market Segment Forecasts and Supplier Shares This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in ... Future French Tumor Marker Testing Market Outlook Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ... |